GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » Equity-to-Asset

Encision (Encision) Equity-to-Asset : 0.51 (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Encision Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Encision's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2.19 Mil. Encision's Total Assets for the quarter that ended in Dec. 2023 was $4.29 Mil. Therefore, Encision's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.51.

The historical rank and industry rank for Encision's Equity-to-Asset or its related term are showing as below:

ECIA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.39   Med: 0.63   Max: 0.76
Current: 0.51

During the past 13 years, the highest Equity to Asset Ratio of Encision was 0.76. The lowest was 0.39. And the median was 0.63.

ECIA's Equity-to-Asset is ranked worse than
66.67% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs ECIA: 0.51

Encision Equity-to-Asset Historical Data

The historical data trend for Encision's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encision Equity-to-Asset Chart

Encision Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.46 0.50 0.57 0.60

Encision Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.60 0.61 0.51 0.51

Competitive Comparison of Encision's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Encision's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encision's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Encision's Equity-to-Asset falls into.



Encision Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Encision's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=2.495/4.134
=0.60

Encision's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2.193/4.287
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Encision  (OTCPK:ECIA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Encision Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Encision's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Encision (Encision) Business Description

Traded in Other Exchanges
N/A
Address
6797 Winchester Circle, Boulder, CO, USA, 80301
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.
Executives
Robert H Fries director 800 FILLMORE ST, DENVER CO 80206
Peter D Geary officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson officer: VP Sales 17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Gregory J. Trudel director, officer: CEO 5241 RIMROCK LANE, FORT COLLINS CO 80526
Brian J Jackman director 6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker director 6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen director, 10 percent owner 4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed 10 percent owner
Patrick W Pace director 3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs officer: VP Engineering 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse officer: VP RA/QA 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton director, officer: VP Technology 8099 NORTH 63RD STREET, LONGMONT CO 80503

Encision (Encision) Headlines

From GuruFocus

Encision Reports Fourth Quarter Fiscal Year 2018 Results

By PRNewswire PRNewswire 05-07-2018

Encision Reports Second Quarter Fiscal Year 2021 Results

By PRNewswire PRNewswire 11-05-2020

Encision Signs Supplier Agreement with Human Xtensions

By ACCESSWIRE ACCESSWIRE 02-28-2023

Encision Reports First Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 08-02-2018

Encision Receives PPP Financing

By PRNewswire PRNewswire 02-10-2021

Encision Reports Fourth Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 05-14-2020

Encision Completes Private Placement of Common Stock

By PRNewswire PRNewswire 12-20-2018

Encision Reports Fourth Quarter Fiscal Year 2021 Results

By PRNewswire PRNewswire 05-19-2021

Encision Reports Second Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 11-06-2018